"Risk of Venous Thromboembolism with Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Trials Program" by Rashmi Dhital

Presentation

Risk of Venous Thromboembolism with Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Trials Program

Arthritis and Rheumatology

Rashmi Dhital, Reading Hospital-Tower Health
Anthony A. Donato, Reading Hospital-Tower Health
Bidhya Timilsina, Reading Hospital
Theresa Lynn, Reading Hospital-Tower Health
Colin Peters, Reading Hospital-Tower Health
Oreoluwa Oladiran, Reading Hospital-Tower Health
Prem Raj Parajuli, Reading Hospital-Tower Health
Prakash Paudel, Berkshire Medical Center

Link

Document Type

Poster Presentation

Publication Date

10-23-2018

Disciplines

Comments

American College of Rheumatology
2018 ACR/ARHP Annual Meeting

ABSTRACT NUMBER: 2813

Citation Information

Rashmi Dhital, Anthony A. Donato, Bidhya Timilsina, Theresa Lynn, et al.. "Risk of Venous Thromboembolism with Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Trials Program" Arthritis and Rheumatology Vol. 70 Iss. 10 Supplement (2018)
Available at: http://works.bepress.com/anthony-donato/45/